FGF21 alleviates microvascular damage following limb ischemia/reperfusion injury by TFEB-mediated autophagy enhancement and anti-oxidative response

• Fanfeng Chen,
• Jiayu Zhan,
• Xiaoqing Yan,
• Abdullah Al Mamun,
• Yu Zhang,
• Yitie Xu,
• Hongyu Zhang,
• Xiaokun Li,
• Kailiang Zhou,
• Jian Xiao

Affiliations

Fanfeng Chen

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University

Jiayu Zhan

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Xiaoqing Yan

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Abdullah Al Mamun

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Yu Zhang

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Yitie Xu

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Hongyu Zhang

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Xiaokun Li

Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University

Kailiang Zhou

Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University

Jian Xiao

Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University